MUR-59802-45126
4 vaccinations
3 coded responses
16 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 430 / OH
- Registered
- 2021-01-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-23
Registered in v-safe
-
2021-01-23
Dose 1 — Pfizer-BioNTech
-
2021-01-23
Survey response — day 0, dose 1MedDRA: Injection site pain — Feeling: GoodFree text: Arm a tiny bit sore at injection site (1-2 out of 10)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-24
Survey response — days 1–6 daily, dose 1MedDRA: Pain in extremity — Feeling: GoodFree text: Sore armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-02-06
-
2021-02-15
Dose 2 — Pfizer-BioNTech
-
2021-02-16
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-17
- 2021-02-22
-
2021-10-10
Dose 3 — Pfizer-BioNTech
-
2022-10-13
Dose 4 — Pfizer-BioNTech
-
2022-10-14
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2022-10-15
- 2022-11-19
-
2023-04-13
Survey response — 6 months, dose 4MedDRA: Abortion spontaneous — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-04-13
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
-
2023-04-14
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-23 | Pfizer-BioNTech | |
| 2 | 2021-02-15 | Pfizer-BioNTech | |
| 3 | 2021-10-10 | Pfizer-BioNTech | No |
| 4 | 2022-10-13 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-04-13 | Successful 2023-04-14 |
Does not wish to fill out VAERS report |
Free text
Release 2 — day 0, dose 1
Systemic reaction (other): Arm a tiny bit sore at injection site (1-2 out of 10)
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Sore arm
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release